Ranked by clinical structure rather than popularity, five entries here survive the filter. Wysa is the only one built as a clinical tool — $99.99/yr, an $8.33 monthly equivalent, a free tier that works, verified 2026-09-14. Rosebud and Mindsera are pattern-recognition instruments rather than conversations. Pi is free with no ceiling and no paid tier to upgrade into. Ash sits between them: therapeutic memory across months, and the one annual price on this list that can cost you more than paying monthly.
The rules follow from that structure. Clinical grounding plus a path to a human: Wysa. Months of entries turned into visible patterns: Rosebud at $8.99/mo, whose annual plan does not lower that rate, or Mindsera, whose paid price exists only inside the app. Free conversation at two in the morning: Pi. Therapeutic memory with weekly insight: Ash — but run the annual arithmetic before paying.
None of the five treats anxiety. They support, structure and reflect, and the claim this article defends is narrower than the marketing attached to any of them.
Clinical structure, not star counts, separates these five
Free is not the filter: 145 of the 154 SFW entries in this directory record a free tier, and 110 of those 154 record memory. What separates these five is what the product does with the sentence you type.
- Escalation. Notices a signal and points outward, to a human. Wysa's listing states clear escalation paths and a clinical rather than romantic framing.
- Pattern analysis. Accumulates entries and returns a reading. Rosebud calls it emotional analysis and long-term patterns; Mindsera, mental-model prompts and Big Five insights.
- Retention. Remembers you across months so the next conversation starts where the last ended. Ash, with weekly insight on top.
- Listening. Answers warmly without pretending to be a program. Pi.
Popularity ranks installation counts, not whether a product was built for the problem you brought. The wellbeing tag holds the wider set; the axis above is what orders this one.
Wysa: the only entry built as a clinical tool
Wysa's two prices look like billing periods and are actually two products. Premium is $99.99/yr — $8.33/mo. Premium Plus, which adds a human coach, is $99.99/mo. Comparing $8.33 with $99.99 compares a self-help toolkit with a coached program sold monthly only. The listing, verified 2026-09-14, records no monthly option for the toolkit tier: annual is the only way it is sold, not a discount pushed at you. Twelve months is one payment of $99.99, and there is no second billing period to arbitrage.
What the money buys is structure. The free tier is functional, and the verdict is blunt: the product is honest about being a tool rather than a relationship. Evidence-based techniques, clear escalation, no performed intimacy; the cons section says it is not a companionship product, which describes the design rather than criticising it.
Two constraints decide availability: iOS and Android only, no web client; and a thin capability row — memory yes, voice no, calls no, so speaking entries aloud is not supported.
Rosebud and Mindsera: pattern recognition from two directions
Both turn writing into a reading of you and work in a browser as well as on a phone. The resemblance ends at the method.
Rosebud is $8.99/mo, and the annual equivalent is also $8.99/mo, verified 2026-09-30. Twelve payments cost $107.88; an annual plan converting to the same rate costs the same $107.88. Annual buys one less transaction and no saving — worth stating plainly, because the reflex is to assume annual undercuts monthly.
For that money it is a journal with a reader attached: typed or spoken entries, emotional analysis, patterns visible only across weeks. The free tier is described as genuinely usable rather than a demo, which matters when the value arrives late. Its two limits are the price of the design: journaling and not roleplay, and the deepest analysis behind the subscription.
Mindsera answers a different question and refuses the price one. Free covers journal basics; the Genius plan bills monthly or annually, and the price appears only inside the app, recorded that way on 2026-09-30 — the one entry you cannot budget for from outside, so the figure stays blank here rather than estimated.
What it offers instead: more than fifty guided frameworks, cognitive prompts in the CBT tradition, Big Five insights, and a specific privacy statement — entries encrypted at rest and in transit, not used to train AI models. Web, iOS and Android; custom characters recorded; voice and calls not.
The split is mechanical: want a reflection on what you wrote, choose Rosebud; want a framework that tells you which question to answer plus a personality readout, choose Mindsera, and accept learning the price at checkout.
Ash: therapeutic memory, and an annual plan that can cost more
Ash has the most interesting price here, and the listing, verified 2026-09-29, is precise enough to do arithmetic: premium launched September 2026 at $9.99–$39.99/mo, or $169.99/yr — about $14.16/mo — with a seven-day trial.
At the bottom of that range, $9.99 monthly, twelve months cost $119.88, which is $50.11 less than $169.99. So the annual plan only beats monthly if your tier costs more than $14.16/mo. The listing does not tie the annual price to a specific tier, which makes that the question to settle before paying: below $14.16/mo, annual costs you money.
This is the inversion worth remembering about the category. Most annual plans exist to cut the monthly rate; this one cuts it only near the top of the range. Sorted by the annual column, Ash looks expensive; sorted by monthly entry price, it sits in the middle of the five.
Underneath is the closest thing here to companion plus clinic. Memory persists across months, which makes weekly insight meaningful rather than decorative, and the model is described as purpose-built for psychology rather than a general assistant with a sympathetic prompt. Voice and calls both recorded — only 25 of the 243 entries in this directory record voice calls at all. iOS and Android.
Two cautions come from the listing: premium is new and still settling, and the product states that it is not for crisis situations, a boundary of the design rather than a legal footnote.
Pi: free, unlimited, and deliberately not clinical
Pi is $0 with no usage limit, no paid tier and no card required, verified 2026-09-14. No monthly-versus-annual comparison exists because nothing is for sale — the only entry here with no pricing asymmetry at all.
Free is usually a funnel; here it is not. The verdict calls it completely free, genuinely warm and free of an upsell wall, and records memory, voice and calls on web, iOS and Android. Twenty-five of 243 entries record voice calls; Pi is one of them and costs nothing.
Its limits are structural. Not roleplay, so no character to build and no persona carried across months; active memory described as shallow next to a memory-first companion; and no therapeutic claim at all, which is why it sits at the bottom of the clinical axis and the top of the availability axis. For many people the realistic first step is a free conversation at two in the morning.
What none of these five can do
No entry diagnoses anything. Wysa frames itself clinically, Ash's listing says it is not a medical device, and neither claims to assess you — a companion offering a diagnosis would be making a claim no listing here supports.
No entry provides crisis response. Ash says explicitly that it is not for crisis use, and Wysa's differentiator is escalation to a human rather than intervention in the moment. An escalation path hands you to a person; it is not a substitute for one.
Memory is not understanding. 110 of the 154 SFW entries record it, so the flag no longer separates a product that knows you from one that stores you. Ash's weekly insight and Rosebud's pattern analysis are readings; retention alone is storage. The long-term memory list compares the retention-first products, which is a different shortlist from this one.
Privacy is not uniform: Mindsera encrypts entries at rest and in transit and says they are not used to train models; Ash describes a privacy-first design with anonymous use supported; Wysa frames privacy clinically with clear escalation paths. These are claims from listings rather than audits, and worth reading before typing something you would not want retained.
One boundary is not about software. If low mood has lasted more than a couple of weeks, is affecting work or sleep, or involves thoughts of harming yourself, the next step is a clinician or a local crisis line, not an app with a subscription. No price on this page changes that.
Decision checklist
- You want clinical grounding and a route to a human. Wysa: $99.99/yr, an $8.33 monthly equivalent, free tier usable, iOS and Android only.
- You want a person coaching you too. Wysa Premium Plus at $99.99/mo — a different product, not the annual toolkit billed monthly.
- You want entries that become visible patterns. Rosebud at $8.99/mo, and do not pay annually expecting a discount: the annual equivalent is the same $8.99.
- You want frameworks and a personality readout. Mindsera, free for basics, with the paid price visible only inside the app.
- You want therapeutic memory and weekly insight. Ash, but check your tier first: below $14.16/mo, the $169.99 annual plan costs more than twelve monthly payments.
- You want to talk tonight with no card and no meter. Pi: free, unlimited, voice and calls, on web, iOS and Android.
- You work at a keyboard all day. Rosebud, Mindsera and Pi run in a browser; Wysa and Ash are mobile only.
- You want to speak rather than type. Rosebud and Pi record voice; Wysa and Mindsera do not; Ash records voice and calls.
- Symptoms are affecting work or sleep, or include thoughts of self-harm. None of the five — see a clinician or a local crisis line.
Disclosure: the team that runs this directory also builds SoulChat, an AI companion product competing in this category. It is not part of this comparison, it is not a paid placement, and the ranking above is unaffected by it.
How this was checked. Prices, free-tier terms, platform coverage, capability flags and privacy notes were read from the five listings with the verification dates stated above — Wysa and Pi on 2026-09-14, Ash on 2026-09-29, Rosebud and Mindsera on 2026-09-30. Monthly-to-annual conversions are arithmetic on those recorded figures. Where a vendor does not publish a price, as with Mindsera's Genius plan, the figure is left blank rather than estimated. No product here was tested first-hand for this article.